Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maximilian Kerkhoff
Observed names:
Kerkhoff, Maximilian,
M. Kerkhoff
Institutions:
National Center for Tumor Diseases,
Essen University Hospital,
Deutsches Konsortium für Translationale Krebsforschung
Observed institutions:
National Center for Tumor Diseases,
Essen University Hospital,
Deutsches Konsortium für Translationale Krebsforschung,
Stiftung Universitätsmedizin Essen,
University of Duisburg-Essen
ORCID:
0009-0004-4458-1609
Observed ORCID:
0009-0004-4458-1609
OpenAlex ID:
A5055773673
Evaluation of the Effect of Photodynamic Therapy on CAM-Grown Sarcomas
2023
·
Maximilian Kerkhoff
, Susanne Grunewald
, et al.
·
Bioengineering
·
7
PDF
Ewing Sarcoma as Secondary Malignant Neoplasm—Epidemiological and Clinical Analysis of an International Trial Registry
2022
·
Stefan K. Zöllner
, Katja L. Kauertz
, et al.
·
Cancers
·
7
PDF
Potential biomarkers of Ewing sarcoma identified through a Europe-wide analysis of prospectively collected samples
2026
·
Andreas Ranft
, Günther H. S. Richter
, et al.
·
Scientific Reports
·
4
PDF
The Puzzle of Genetic Stability and Chromosomal Copy Number Alterations for the Therapy of Ewing Sarcoma
2025
·
Günther H. S. Richter
, Andreas Ranft
, et al.
·
Cancers
·
3
PDF
Characterization of a novel sarcoma cell line with an EWSR1::POU2AF3 fusion
2025
·
Hannah Schwab
, Maximilian Kerkhoff
, et al.
·
Pathology & Oncology Research
·
2
New cell lines expanding the diversity of Ewing sarcoma models
2025
·
Maximilian Kerkhoff
, Christiane Schaefer
, et al.
·
International Journal of Cancer
·
1
Elimusertib enhances cytotoxic effects of conventional chemotherapy and sensitizes to radiation in preclinical Ewing sarcoma models
2026
·
Leonhard Koch
, Maximilian Kerkhoff
, et al.
·
Scientific Reports
PDF
Establishment and characterization of new models for the research on sarcomas
2025
·
Kerkhoff, Maximilian
·
Universitätsbibliographie, Universität Duisburg-Essen
423 (PB411): Characterization and evaluation of the protein kinase BUB1B as therapeutic target in ewing sarcoma
2024
·
C. Schaefer
, M. Kerkhoff
, et al.
·
European Journal of Cancer
Abstract 6730: Preclinical testing of lestaurtinib (CEP701) as a single and combination agent for the treatment of Ewing sarcoma
2023
·
Samet Dayi
, Christiane Schaefer
, et al.
·
Cancer Research
Show more works
View as search
Works count:
11
Citation count:
24
H-index:
3
I10-index:
Year
Topic
Type